In separate statistical analyses, no association of DLL3 expression with survival was observed in NEC (p = 0.32; data not shown), which was also the case in separate analyses in pulmonary (p = 0.708) and GEP-NEC (p = 0.87) (Supplementary Fig. 4A–B). This evidence concerns the gene DLL3 and neuroendocrine carcinoma.